3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
5
Phase 3
2
Phase 2
2
Phase 1/2
2
Phase 1
1
Status
Suspended
1
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
1
Breast
1
Conditions
Prostatic Neoplasms
1
Breast Carcinoma In Situ
1
Interventions
pembrolizumab
223
Carboplatin
217
Cisplatin
205
Paclitaxel
182
Gemcitabine
149
Docetaxel
127
Capecitabine
114
Dexamethasone
102
Pemetrexed
101
Cyclophosphamide
101
Specimen Handling
99
Magnetic Resonance Spectroscopy
97
Oxaliplatin
96
Radiotherapy
94
Doxorubicin
90
Fluorouracil
88
Bevacizumab
83
Nivolumab
74
Leucovorin
73
Rituximab
70
durvalumab
66
Vincristine
66
Lenalidomide
64
Irinotecan
61
Etoposide
61
atezolizumab
60
Radiation
60
130-nm albumin-bound paclitaxel
57
Prednisone
56
Letrozole
54
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Absorptiometry, Photon
×
1 year
×
Clear all
NCT06671912
2026-06-02
LoTam
Alliance for Clinical Trials in Oncology
Phase 3
Suspended
1,156 enrolled
NCT05838716
2026-01-15
ViPER
University of Rochester
Phase 3
Recruiting
240 enrolled